The Supreme Court will allow a challenge to Texas' controversial abortion law; the FDA broadens booster eligibility for teens; Kentucky declares an emergency over nurse shortages.
Although the law must remain in place throughout the duration, the Supreme Court announced it will permit a challenge against Texas' controversial abortion law, known as S.B.8., The New York Times reports. The law, which bans most abortions after 6 weeks of pregnancy and has no exceptions for rape or incest, has stoked controversy since it was put into effect in September. Specifically, the Supreme Court will allow abortion providers in the state to sue some state officials in federal court. S.B.8. permits private individuals to sue anyone in the state who performs an abortion or aids or abets the procedure.
The FDA has endorsed providing Pfizer/BioNTech booster shots to those aged 16 and 17, USAToday reports. Hours after the FDA authorized the move, the CDC recommended these teens receive the boosters as soon as 6 months have passed following their initial shots. The third dose of the Pfizer/BioNTech vaccine is identical to the previous 2 in the regimen. Booster doses are already encouraged for those aged 18 and older who received any of the 3 approved vaccines. All booster doses will be free of charge to those who qualify.
Kentucky has declared an emergency due to a chronic lack of nurses, according to The Associated Press. As a result, Governor Andrew Beshear took executive actions to boost enrollment in nurse training programs throughout the state. By 2024, the state is projected to need over 16,000 additional nurses to help fill gaps resulting from retirement or individuals leaving the profession. The COVID-19 pandemic also has exacerbated nursing shortages across the country, as many leave because of exhaustion or the demoralizing nature of the job, or take more lucrative positions with travelling nurse agencies.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
2 Commerce Drive
Cranbury, NJ 08512